Ocular manifestations of graft-versus-host disease

Amr Nassar, Khalid F. Tabbara, Mahmoud Aljurf

Research output: Contribution to journalArticle

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two decades to become the standard of care for hematologic and lymphoid malignancies. Major ocular complications after allogeneic HSCT have been increasing in number and severity. Graft-versus-host disease (GVHD) remains a major cause of ocular morbidity after allogeneic HSCT. The main objective of this review is to elucidate the ocular complications in patients developing GVHD following HSCT. Ocular complications secondary to GVHD are common and include dry eye syndrome, acquisition of ocular allergy from donors with allergic disorders. Eyelid changes may occur in GVHD leading to scleroderma-like changes. Patients may develop poliosis, madarosis, vitiligo, lagophthalmos, and entropion. The cornea may show filamentary keratitis, superficial punctate keratitis, corneal ulcers, and peripheral corneal melting which may lead to perforation in severe cases. Scleritis may also occur which can be anterior or posterior. Keratoconjunctivis sicca appears to be the most common presentation of GVHD. The lacrimal glands may be involved with mononuclear cell infiltration of both the major and accessory lacrimal glands and decrease in tear production. Severe dry eye syndrome in patients with GVHD may develop conjunctival scarring, keratinization, and cicatrization of the conjunctiva.Therapy of GVHD includes systemic immunosuppression and local therapy. Surgical treatment in refractory cases includes surgical intervention to improve the manifestation of GVHD of the eye. This may include tarsorrhapy, prose lenses, punctal occlusions and corneal transplantation.

Original languageEnglish (US)
Pages (from-to)215-222
Number of pages8
JournalSaudi Journal of Ophthalmology
Volume27
Issue number3
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Eye Manifestations
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Dry Eye Syndromes
Lacrimal Apparatus
Keratitis
Cicatrix
Entropion
Scleritis
Corneal Ulcer
Vitiligo
Corneal Transplantation
Conjunctiva
Hematologic Neoplasms
Eyelids
Standard of Care
Tears
Cornea
Immunosuppression
Freezing

Keywords

  • Graft-versus-host disease
  • Ocular
  • Transplantation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ocular manifestations of graft-versus-host disease. / Nassar, Amr; Tabbara, Khalid F.; Aljurf, Mahmoud.

In: Saudi Journal of Ophthalmology, Vol. 27, No. 3, 07.2013, p. 215-222.

Research output: Contribution to journalArticle

Nassar, Amr ; Tabbara, Khalid F. ; Aljurf, Mahmoud. / Ocular manifestations of graft-versus-host disease. In: Saudi Journal of Ophthalmology. 2013 ; Vol. 27, No. 3. pp. 215-222.
@article{0887165213ca4dba8cda94dd0105e1aa,
title = "Ocular manifestations of graft-versus-host disease",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two decades to become the standard of care for hematologic and lymphoid malignancies. Major ocular complications after allogeneic HSCT have been increasing in number and severity. Graft-versus-host disease (GVHD) remains a major cause of ocular morbidity after allogeneic HSCT. The main objective of this review is to elucidate the ocular complications in patients developing GVHD following HSCT. Ocular complications secondary to GVHD are common and include dry eye syndrome, acquisition of ocular allergy from donors with allergic disorders. Eyelid changes may occur in GVHD leading to scleroderma-like changes. Patients may develop poliosis, madarosis, vitiligo, lagophthalmos, and entropion. The cornea may show filamentary keratitis, superficial punctate keratitis, corneal ulcers, and peripheral corneal melting which may lead to perforation in severe cases. Scleritis may also occur which can be anterior or posterior. Keratoconjunctivis sicca appears to be the most common presentation of GVHD. The lacrimal glands may be involved with mononuclear cell infiltration of both the major and accessory lacrimal glands and decrease in tear production. Severe dry eye syndrome in patients with GVHD may develop conjunctival scarring, keratinization, and cicatrization of the conjunctiva.Therapy of GVHD includes systemic immunosuppression and local therapy. Surgical treatment in refractory cases includes surgical intervention to improve the manifestation of GVHD of the eye. This may include tarsorrhapy, prose lenses, punctal occlusions and corneal transplantation.",
keywords = "Graft-versus-host disease, Ocular, Transplantation",
author = "Amr Nassar and Tabbara, {Khalid F.} and Mahmoud Aljurf",
year = "2013",
month = "7",
doi = "10.1016/j.sjopt.2013.06.007",
language = "English (US)",
volume = "27",
pages = "215--222",
journal = "Saudi Journal of Ophthalmology",
issn = "1319-4534",
publisher = "King Saud University",
number = "3",

}

TY - JOUR

T1 - Ocular manifestations of graft-versus-host disease

AU - Nassar, Amr

AU - Tabbara, Khalid F.

AU - Aljurf, Mahmoud

PY - 2013/7

Y1 - 2013/7

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two decades to become the standard of care for hematologic and lymphoid malignancies. Major ocular complications after allogeneic HSCT have been increasing in number and severity. Graft-versus-host disease (GVHD) remains a major cause of ocular morbidity after allogeneic HSCT. The main objective of this review is to elucidate the ocular complications in patients developing GVHD following HSCT. Ocular complications secondary to GVHD are common and include dry eye syndrome, acquisition of ocular allergy from donors with allergic disorders. Eyelid changes may occur in GVHD leading to scleroderma-like changes. Patients may develop poliosis, madarosis, vitiligo, lagophthalmos, and entropion. The cornea may show filamentary keratitis, superficial punctate keratitis, corneal ulcers, and peripheral corneal melting which may lead to perforation in severe cases. Scleritis may also occur which can be anterior or posterior. Keratoconjunctivis sicca appears to be the most common presentation of GVHD. The lacrimal glands may be involved with mononuclear cell infiltration of both the major and accessory lacrimal glands and decrease in tear production. Severe dry eye syndrome in patients with GVHD may develop conjunctival scarring, keratinization, and cicatrization of the conjunctiva.Therapy of GVHD includes systemic immunosuppression and local therapy. Surgical treatment in refractory cases includes surgical intervention to improve the manifestation of GVHD of the eye. This may include tarsorrhapy, prose lenses, punctal occlusions and corneal transplantation.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved over the past two decades to become the standard of care for hematologic and lymphoid malignancies. Major ocular complications after allogeneic HSCT have been increasing in number and severity. Graft-versus-host disease (GVHD) remains a major cause of ocular morbidity after allogeneic HSCT. The main objective of this review is to elucidate the ocular complications in patients developing GVHD following HSCT. Ocular complications secondary to GVHD are common and include dry eye syndrome, acquisition of ocular allergy from donors with allergic disorders. Eyelid changes may occur in GVHD leading to scleroderma-like changes. Patients may develop poliosis, madarosis, vitiligo, lagophthalmos, and entropion. The cornea may show filamentary keratitis, superficial punctate keratitis, corneal ulcers, and peripheral corneal melting which may lead to perforation in severe cases. Scleritis may also occur which can be anterior or posterior. Keratoconjunctivis sicca appears to be the most common presentation of GVHD. The lacrimal glands may be involved with mononuclear cell infiltration of both the major and accessory lacrimal glands and decrease in tear production. Severe dry eye syndrome in patients with GVHD may develop conjunctival scarring, keratinization, and cicatrization of the conjunctiva.Therapy of GVHD includes systemic immunosuppression and local therapy. Surgical treatment in refractory cases includes surgical intervention to improve the manifestation of GVHD of the eye. This may include tarsorrhapy, prose lenses, punctal occlusions and corneal transplantation.

KW - Graft-versus-host disease

KW - Ocular

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84883463939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883463939&partnerID=8YFLogxK

U2 - 10.1016/j.sjopt.2013.06.007

DO - 10.1016/j.sjopt.2013.06.007

M3 - Article

C2 - 24227989

AN - SCOPUS:84883463939

VL - 27

SP - 215

EP - 222

JO - Saudi Journal of Ophthalmology

JF - Saudi Journal of Ophthalmology

SN - 1319-4534

IS - 3

ER -